Laboreve sells the three actives every buyer asks for — and PDRN is the only one you can actually stock

Exosome, EGF and PDRN arrive in the same sourcing brief and get treated as one shopping list. Our catalogue says they are nothing alike in availability: 43 PDRN products, 20 EGF, 10 exosome. The active everyone writes into a brief is the one barely anybody makes.

Laboreve is unusual for carrying all three — one per step of a single routine, all sitting on the same proprietary peach postbiotic the brand calls PeachBiome028.

Why the routine shape matters

A buyer listing three unrelated hero products has to explain each one. A buyer listing a routine sells the second and third SKU on the strength of the first. Laboreve designed that attachment in rather than leaving it to the retailer — toner, serum, cream, one platform underneath, three different headline actives on top.

The toner is the interesting listing. PDRN is usually sold as an ampoule; a toner at 78% postbiotic content with PDRN is a differentiated shelf position rather than a me-too.

The cream is the technically loaded one — exosome content alongside a triple-acid complex and four ceramides. Exfoliating acids inside a barrier cream is an unusual combination and worth feeling on your own skin before you write a listing claim around it.

Our call

Carry it if you want to own the regenerative-actives conversation with one supplier relationship instead of three, and your channel can merchandise a set. The platform story also gives your staff something to say that is not just an ingredient name.

Skip it — or at least sequence it — if you are shipping into the EU this quarter. Certification coverage here is thin — the matrix above is the whole of what is on file — and that is a conversation to have before the order, not after. Ask us and we will get the documents.